NCT02428829

Brief Summary

This study looks to examine the effect of attempting initial postoperative walking with a patient following a total hip replacement. Currently patients rest in bed for approximately 24 hours following their operation before walking. The intervention group would aim to commence walking at between 4-6 hours after their operation. Outcome measures to be examined would be: length of hospital stay, patient experience of physiotherapy treatment, the time taken for patients to reach functional milestones and number of postoperative medical complications. The study is designed as a randomised controlled trial where participants would be separated randomly into two groups. One group would form the intervention group and start physiotherapy and attempted walking 4-6 hours after their operation. The other group would form the control group and would remain on the current standard rehabilitation protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
212

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

April 21, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 29, 2015

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

January 29, 2020

Status Verified

January 1, 2020

Enrollment Period

4.4 years

First QC Date

April 21, 2015

Last Update Submit

January 27, 2020

Conditions

Keywords

hipreplacementarthroplastytotalorthopaedicrehabiliationphysiotherapytherapy

Outcome Measures

Primary Outcomes (1)

  • Length of inpatient hospital stay following return to the ward after total hip replacement

    This is measured in number of days. The study would determine a change in length of stay by one day clinically significant.

    7 days

Secondary Outcomes (4)

  • Patient satisfaction with physiotherapy care following completion of physiotherapy care as measured by completion of patient satisfaction questionnaire results

    12 weeks

  • Time taken for patients to reach functional milestones postoperatively

    4 hours

  • The incidence rate of postoperative complications

    12 weeks

  • Numerical pain scores for the patients postoperative pain

    12 weeks

Study Arms (2)

Intervention

EXPERIMENTAL

Intervention group will be seen by a physiotherapist to attempt walking from 4 hours post operatively, on the day of their surgery.

Procedure: Attempt walking from 4 hours post operatively, on the day of their surgery.

Control

ACTIVE COMPARATOR

Control group will receive standard physiotherapy in line with current hospital protocol including first walking approximately 24 hours post operatively

Procedure: Control - standard treatment

Interventions

Intervention group will be seen by a physiotherapist to attempt walking from 4 hours post operatively, on the day of their surgery.

Intervention

standard physiotherapy in line with current hospital protocol including first walking approximately 24 hours post operatively.

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to give informed written consent
  • Able to understand verbal and written communication in English
  • Over 18 years of age
  • Primary Uni-lateral Total Hip Replacement (THR)
  • No intra-operative complications
  • Weight bearing status:
  • Fully Weight Bearing
  • Weight Bearing as Tolerated.
  • Adequate home support to facilitate timely discharge.

You may not qualify if:

  • No current or historical serious co-morbidities:
  • Cerebro-Vascular Accident (CVA)
  • Myocardial Infarction (MI)
  • Pulmonary Embolism (PE)
  • Deep Vein Thrombosis (DVT) o Diabetes Mellitus (DM)
  • Significant intra or post-operative wound ooze
  • Poor pre-morbid mobility/level of function (House or wheelchair bound)
  • Clinical signs of DVT or PE
  • Altered Weight-Bearing status
  • Repair to abductor muscle complex
  • Nerve block as part of anaesthetic
  • Participation in any other research trials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

Bournemouth, Dorset, BH7 7DW, United Kingdom

Location

Study Officials

  • Christopher Efford, BSc(Hons)

    Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2015

First Posted

April 29, 2015

Study Start

April 1, 2015

Primary Completion

September 1, 2019

Study Completion

December 1, 2019

Last Updated

January 29, 2020

Record last verified: 2020-01

Locations